Astria Therapeutics Inc. has announced the granting of stock options to purchase 119,860 shares of its common stock as part of the 2022 Inducement Stock Incentive Plan. This initiative is designed for individuals who were not previously employed by the company. The options, granted on July 1, 2025, come with an exercise price of $5.43 per share, reflecting the closing price on the grant date. The vesting schedule spans four years, with 25% of the shares vesting on the first anniversary of the employee's start date and the remainder vesting monthly over the subsequent 36 months, contingent on continued employment with Astria. These options are governed by the 2022 Inducement Stock Incentive Plan and an award agreement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.